Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

HealthRX vs Strut Health

Two GLP-1 desks, one scoreboard. We put HealthRX and Strut Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 7 · Grade B

HealthRX

Visit HealthRX Full brief →
vs
No. 18 · Grade B

Strut Health

Visit Strut Health Full brief →

The verdict

HealthRX takes this head-to-head.

HealthRX scores 86 to 84 on our six-factor Brief Score — A LegitScript-certified, physician-supervised desk (healthrx.com) whose real hook is breadth: injectable and a rare oral GLP tablet, on both molecules, with transparent no-insurance monthly pricing.

That doesn't make Strut Health a bad call — it's best for readers who want a needle-free route at the lowest tracked price and are comfortable with a recurring auto-refill. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
85
84
Supply Reliability
85
82
Transparency
83
86
Access Breadth
91
86
Clinical Oversight
89
82
Track Record
81
84
HealthRXBrief Score 86 · 84Strut Health

Price, coverage & the tracker

HealthRXStrut Health
Brief Score86/100 (B)84/100 (B)
Semaglutide$189/mo$99/mo lozenge · $149/mo injectable (auto-refill)
Tirzepatide$349/mo$199/mo lozenge · $199/mo injectable (auto-refill)
CoverageNot publicly listed49 states (not Alaska)
Brand-name accessYesCompounded only
Oral / sublingualYesYes
On the trackerStableprice stableStableprice stable

HealthRX: Company-stated tiers held flat this cycle; the LegitScript badge and a rare oral GLP tablet are the draw, but some tiers are self-reported rather than checkout-verified.

Strut Health: Cheapest oral route we track at $99 — but only on auto-refill; the one-off rate runs higher.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.